Embryo Watch

A new culture system allows researchers to track the development of human embryos in vitro for nearly two weeks.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

drawing of sperm fertilizing egg oocyteFLICKR, INTERNET ARCHIVE BOOK IMAGESA young embryo implants into the wall of the womb about seven days after fertilization. The first week of embryonic development is fairly straightforward to study in vitro; after that, it gets tricky. But a new blend of amino acids, hormones, and growth factors now provides researchers with a way to keep human embryos alive in vitro for much longer. In two separate studies published in Nature and Nature Cell Biology yesterday (May 4), researchers cultured and watched human embryos develop for a total of 13 days post-fertilization. (International regulations permit the study of human embryos in the lab for up to 14 days.) The research revealed that stem cells in the blastocyst self-organize into a cavity that was once thought to be formed by apoptosis, confirmed differences between murine and human development, and suggested that the embryo initially develops largely without any input from mom.

“This is the period of our lives that some of the most important [biological] decisions are made,” the University of Cambridge’s Magdalena Zernicka-Goetz, whose group developed the culture system and has already demonstrated its utility in culturing mouse embryos, told The Wall Street Journal. “It was entirely a black box of development that we were not able to access until now.”

Zernicka-Goetz, an author on the Nature Cell Biology paper, noted that many developmental defects occur shortly following implantation. “This new technique provides us with a unique opportunity to get a deeper understanding of our own development during these crucial stages and help us understand what happens, for example, during miscarriage,” she said in a press release.

The system could allow researchers to track ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies